What is Allertech Laboratories?
Allertech Laboratories, established in 2012, is a specialized entity focused on the identification, diagnosis, and treatment of allergies. The company offers comprehensive solutions, including advanced testing methodologies and allergy immunotherapy, with a commitment to personalized patient care that addresses the root causes of allergic conditions. Beyond direct patient services, Allertech Laboratories also empowers medical practices by assisting them in establishing operational allergy labs, thereby enhancing both patient care delivery and practice revenue streams. Their business model is designed to foster partnerships with medical professionals, facilitating the integration of effective allergy treatment protocols within their existing frameworks.
How much funding has Allertech Laboratories raised?
Allertech Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Allertech Laboratories?
The substantial backing indicated by $150K suggests Allertech Laboratories is poised for significant scaling and market penetration. Given the context of a large-scale, late-stage funding round and a major strategic investment, the company is likely to focus on expanding its service offerings, enhancing its technological infrastructure for allergy diagnostics, and potentially broadening its geographical reach. Future developments may include further innovation in immunotherapy treatments and increased support for medical practices looking to capitalize on the growing demand for specialized allergy services.
See full Allertech Laboratories company page
